Skip to main content

Day: March 25, 2024

Ultimovacs ASA: Notice of Annual General Meeting on April 18, 2024

Oslo, March 25, 2024, the Board of Directors hereby calls for the Annual General Meeting of Ultimovacs ASA (the “Company”) at 14:00 CET on April 18, 2024. The General Meeting will be held electronically. For participation, please log in at https://dnb.lumiagm.com/137559337. All documents regarding the Annual General Meeting are available at the Company’s website: www.ultimovacs.com For further information, please see www.ultimovacs.com or contact: Jónas Einarsson, Chairman of the Board of Directors of Ultimovacs ASA Email: je@radforsk.no Phone: +47 480 96355 Carlos de Sousa, CEO Email: carlos.desousa@ultimovacs.com Phone: +47 908 92507          Anne Worsøe, Head of Investor Relations and ESG Email: anne.worsoe@ultimovacs.com Phone: +47 906 86815AttachmentsUltimovacs ASA Notice of Annual General Meeting...

Continue reading

Nyxoah Advances Patient Access Strategy through Partnership with the American Association of Otolaryngology – Head & Neck Surgery Foundation

Nyxoah Advances Patient Access Strategy through Partnership with the American Association of Otolaryngology – Head & Neck Surgery FoundationFirst medical device company to become a corporate champion at the ENTerprise Circle level Mont-Saint-Guibert, Belgium – March 25, 2024, 7:05am CET / 2:05am ET – Nyxoah SA (Euronext Brussels/Nasdaq: NYXH) (“Nyxoah” or the “Company”), a medical technology company focused on the development and commercialization of innovative solutions to treat Obstructive Sleep Apnea (OSA), today announced that the Company has signed a strategic partnership to become a Corporate Champion at the ENTerprise Circle level with the American Association of Otolaryngology – Head & Neck Surgery Foundation (AAO-HNSF). Nyxoah is the first medical device company to partner with the AAO-HNSF at this level. The AAO-HNSF...

Continue reading

Icelandic Salmon – Mandatory notification of trade

Pactum Vekst AS has March 22, 2024 sold 123 879 shares in Icelandic Salmon AS at a price of NOK 129,00 per share. Espen W. Marcussen, Chair of the board in Pactum Vekst AS, is a primary insider and board member of Icelandic Salmon AS. Pactum Vekst AS is fully owned by Pactum AS. The shares in Icelandic Salmon are sold to one of Pactum’s shareholders, as part of a share buy-back process in Pactum. After the transaction, Pactum Vekst AS owns 701 983 shares in Icelandic Salmon AS. Please see attached document in accordance with the Market Abuse Regulation article 19. This notification has been submitted pursuant to the Securities Trading Act section 5-12. This information is subject to the disclosure requirements pursuant to Section 5-12 the Norwegian Securities Trading ActAttachmentISLAX_Notification of trade_Espen Marcussen_board...

Continue reading

VIDEO: Dorney Park Releases First Official ON RIDE Point of View Video from New Iron Menace Roller Coaster

Dive Roller Coaster Boasts 95-Degree Drop, 4 Inversions Allentown, PA, March 25, 2024 (GLOBE NEWSWIRE) — ALLENTOWN, PA (March 25, 2024) – The Northeast’s highly anticipated, first-ever dive roller coaster Iron Menace is on the move and cameras are already capturing some of the dynamic testing underway at the Allentown, Pennsylvania amusement park. This morning the park released the first official on ride point of view video. It shows one of the 21-seat trains diving down the 160 foot high, 95-degree drop, before flying at speeds of up to 64 miles per hour across the brand-new track. Iron Menace boasts four inversions including a tilted loop, which is the first of its kind for a dive roller coaster, in addition to some dynamic theming that pays homage to the Lehigh Valley’s rich industrial history. “2024 will be a historic year...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.